Global Pharmaceuticals & Biotech Big Green Snowflakes

Quanterix

Market Cap: US$211.4m

A life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions.

Emergent BioSolutions

Market Cap: US$404.4m

A life sciences company, provides preparedness and response solutions for accidental, deliberate, and naturally occurring public health threats in the United States.

Sunshine Biopharma

Market Cap: US$6.2m

Operates as a pharmaceutical company that focuses on the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada.

Enliven Therapeutics

Market Cap: US$1.2b

A clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule inhibitors to help patients with cancer.

Green Thumb Industries

Market Cap: CA$2.7b

Manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States.

Senti Biosciences

Market Cap: US$36.4m

A clinical stage biotechnology company, develops cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases.

Agilent Technologies

Market Cap: US$36.5b

Provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide.

Bio-Techne

Market Cap: US$8.5b

Develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide.

Noile-Immune Biotech

Market Cap: JP¥8.7b

Researches and develops CAR-T cells for cancer immunotherapies.

Caliway Biopharmaceuticals

Market Cap: NT$399.4b

Engages in the development of drugs for aesthetic medicine and chronic inflammation.

Innoviva

Market Cap: US$1.3b

Engages in the development and commercialization of pharmaceutical products in the United States and internationally.

Neurocrine Biosciences

Market Cap: US$14.3b

Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, neuroendocrine, and neuropsychiatric disorders in the United States and internationally.

Cabaletta Bio

Market Cap: US$155.5m

A clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with autoimmune diseases.

Insmed

Market Cap: US$30.7b

Develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally.

Shanghai Rightongene Biotechnology

Market Cap: CN¥1.7b

Shanghai Rightongene Biotechnology Co., Ltd.

DK Life Science

Market Cap: ₩135.9b

A pharmaceutical company, develops and sells diagnostic medicines and medical devices in South Korea, the European Union, Japan, and internationally.

Radiopharm Theranostics

Market Cap: AU$68.6m

Engages in the research and development of radiopharmaceutical products for diagnostic and therapeutic uses in areas of high unmet medical needs.

Syntara

Market Cap: AU$39.1m

Operates as a clinical-stage drug development company that targets extracellular matrix dysfunction through amine oxidase chemistry and other technologies to develop novel medicines for blood cancers and conditions linked to inflammation and fibrosis in Australia.

Tianjin Tianyao Pharmaceuticals

Market Cap: CN¥4.7b

Tianjin Tianyao Pharmaceuticals Co., Ltd.

Anlon Healthcare

Market Cap: ₹5.1b

Manufactures and sells advance pharmaceutical intermediates in India and internationally.

Alpa Laboratories

Market Cap: ₹2.0b

Engages in the manufacture and sale of pharmaceutical finished dosage forms in India.

Asston Pharmaceuticals

Market Cap: ₹876.7m

Engages in the manufacturing and selling of pharmaceutical formulations and nutraceutical products in India, West Africa, South Africa, and rest of Asia.

Sotac Pharmaceuticals

Market Cap: ₹1.4b

Engages in the production, manufacturing, processing, and sale of various pharmaceutical products in India.

Alector

Market Cap: US$304.6m

A late-stage clinical biotechnology company, develops therapies that is focused on counteracting the devastating progression of neurodegenerative diseases.

Haleon

Market Cap: UK£32.1b

Engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific.

Poltreg

Market Cap: zł121.7m

A biotechnology company, researches and develops therapies for autoimmune diseases.

Auxly Cannabis Group

Market Cap: CA$202.1m

Operates as a consumer packaged goods company in the cannabis products market in Canada.

Scholar Rock Holding

Market Cap: US$3.0b

A biopharmaceutical company, focuses on the discovery, development, and delivery of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role.

Arcturus Therapeutics Holdings

Market Cap: US$484.7m

Engages in the development of infectious disease vaccines and other products within liver and respiratory rare diseases.

BioLineRx

Market Cap: ₪51.2m

A commercial stage biopharmaceutical company, develops and commercializes therapeutics for oncology and rare diseases.

Annexon

Market Cap: US$238.5m

A clinical-stage biopharmaceutical company, discovers and develops medicines for treating inflammatory-related diseases.

Avadel Pharmaceuticals

Market Cap: US$1.5b

Operates as a biopharmaceutical company in the United States.

Celcuity

Market Cap: US$2.4b

A clinical-stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States.

Daewoong Pharmaceutical

Market Cap: ₩1.7t

Develops, manufactures and commercializes pharmaceutical products in South Korea and internationally.

Chong Kun Dang Holdings

Market Cap: ₩231.4b

Manufactures and distributes pharmaceutical products in South Korea and internationally.

Geron

Market Cap: US$893.2m

A commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology.